Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Non-Current Debt (2016 - 2023)

Angiodynamics' Non-Current Debt history spans 13 years, with the latest figure at $49.8 million for Q2 2023.

  • For Q2 2023, Non-Current Debt rose 99.27% year-over-year to $49.8 million; the TTM value through May 2023 reached $49.8 million, up 99.27%, while the annual FY2023 figure was $49.8 million, 99.27% up from the prior year.
  • Non-Current Debt reached $49.8 million in Q2 2023 per ANGO's latest filing, roughly flat from $49.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $126.8 million in Q1 2019 to a low of $14.3 million in Q1 2020.
  • Average Non-Current Debt over 5 years is $45.9 million, with a median of $40.0 million recorded in 2020.
  • Peak YoY movement for Non-Current Debt: crashed 88.69% in 2020, then skyrocketed 109.19% in 2021.
  • A 5-year view of Non-Current Debt shows it stood at $124.4 million in 2019, then plummeted by 67.85% to $40.0 million in 2020, then plummeted by 37.5% to $25.0 million in 2021, then surged by 99.18% to $49.8 million in 2022, then increased by 0.04% to $49.8 million in 2023.
  • Per Business Quant, the three most recent readings for ANGO's Non-Current Debt are $49.8 million (Q2 2023), $49.8 million (Q1 2023), and $49.8 million (Q4 2022).